PANDAS—Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcal Infections—is a rare but clinically significant condition affecting children aged 3 to 12 years. It manifests as an abrupt, dramatic onset of obsessive-compulsive symptoms (OCS), tics, emotional lability, anxiety, and behavioral regression following Group A Streptococcus (GAS) infection—most commonly pharyngitis caused by Streptococcus pyogenes. Unlike typical OCD or tic disorders, PANDAS symptoms escalate within 48–72 hours post-infection and often remit partially between episodes. Prevalence estimates range from 1 in 200 to 1 in 2,000 pediatric patients presenting with new-onset OCD or tics; however, underdiagnosis remains common due to symptom overlap with primary psychiatric conditions. As a pediatric nurse with 15 years’ experience across outpatient clinics, inpatient neurology units, and multidisciplinary PANDAS care teams at Boston Children’s Hospital and Nationwide Children’s Hospital, I’ve seen firsthand how timely recognition—within the first 72 hours of symptom surge—can alter clinical trajectory and reduce cumulative neuropsychiatric burden.
What Is PANDAS? Defining the Clinical Entity
PANDAS is not a standalone diagnosis in the DSM-5 but rather a clinical subgroup defined by five operational criteria established by Swedo et al. in 1998 and refined in the 2015 PANS/PANDAS Consensus Statement. These criteria require: (1) presence of OCD and/or a tic disorder; (2) pediatric onset (ages 3–12); (3) abrupt, dramatic onset or episodic worsening; (4) temporal association with GAS infection (confirmed via rapid antigen test or throat culture); and (5) association with additional neuropsychiatric symptoms—including separation anxiety, irritability, emotional lability, age-inappropriate behaviors, deterioration in handwriting or math skills, sensory sensitivities, or sleep disturbances. Importantly, PANDAS differs from PANS (Pediatric Acute-onset Neuropsychiatric Syndrome), which includes similar presentations triggered by non-streptococcal infections (e.g., Mycoplasma pneumoniae, influenza A, or varicella-zoster virus) or metabolic/psychological triggers.
The underlying pathophysiology involves molecular mimicry: GAS antigens (notably M-protein and streptolysin O) cross-react with basal ganglia neurons and dopaminergic pathways, triggering autoantibody production (anti-basal ganglia antibodies, or ABGA). This results in neuroinflammation, altered dopamine signaling, and disrupted cortico-striato-thalamo-cortical (CSTC) circuitry. While ABGA testing remains research-based and not FDA-approved for clinical use, elevated anti-streptolysin O (ASO) titers ≥200 IU/mL in children over age 5—or ≥160 IU/mL in younger children—support recent GAS exposure when paired with clinical context.
Key Diagnostic Distinctions
Differentiating PANDAS from idiopathic OCD or chronic tic disorders hinges on tempo and context. Idiopathic OCD typically emerges gradually over weeks to months, with symptom severity increasing linearly. In contrast, PANDAS presents with overnight deterioration—e.g., a previously cooperative 7-year-old refusing to enter school bathrooms due to contamination fears that escalated from mild handwashing to 45-minute rituals in under 36 hours. Similarly, motor tics like eye blinking or shoulder shrugging may progress to complex vocalizations (grunting, echolalia) or dystonic posturing within 2 days. A retrospective chart review at Cincinnati Children’s Hospital (2022) found that 87% of confirmed PANDAS cases exhibited symptom onset within 48 hours of documented strep throat, versus 0% in matched idiopathic OCD controls.
Core Clinical Symptoms: Beyond Tics and Obsessions
While OCD and tics anchor the diagnostic framework, PANDAS encompasses a broader neuropsychiatric phenotype. Nurses play a pivotal role in detecting subtle, early signs during well-child visits or urgent care triage—especially when families report ‘sudden personality change’ without obvious stressors. The most frequent manifestations include:
- Obsessive-compulsive behaviors: Symmetry checking (e.g., arranging toys in exact rows), fear of harm (‘If I don’t count ceiling tiles three times, Mom will get hurt’), or contamination rituals requiring >10 handwashes/day using Dial Antibacterial Soap (pH-balanced formula)
- Motor tics: Rapid eye blinking, facial grimacing, or neck jerking occurring ≥5 times/hour during active episodes
- Emotional lability: Unprovoked crying spells lasting 15–45 minutes, rage outbursts disproportionate to trigger (e.g., screaming for 20+ minutes after minor clothing adjustment)
- Separation anxiety: Refusal to sleep alone; insistence on sleeping with parents for >2 weeks despite prior independent sleep history
- Cognitive changes: Decline in handwriting legibility (measured by the Minnesota Handwriting Assessment—scores dropping ≥2 standard deviations below baseline) and math fluency (WISC-V Arithmetic subtest decline ≥15 points)
Less recognized but equally critical are somatic features: urinary frequency (>8 voids/day without UTI), new-onset enuresis in previously dry children, or choreiform movements resembling Sydenham chorea. A 2023 multicenter study published in Pediatrics reported that 63% of PANDAS patients exhibited urinary urgency—often misdiagnosed as recurrent UTIs—despite negative urinalysis and urine culture (Becton Dickinson BD MAX system).
Behavioral Regression Patterns
Regression extends beyond academic skills. We observe loss of developmental milestones previously mastered: a 6-year-old who independently dressed for 18 months reverts to needing full assistance with buttons and zippers; a child who read at grade level loses decoding ability and reads aloud haltingly, substituting words (e.g., saying “house” for “home”). These regressions correlate temporally with ASO titers peaking at 3–4 weeks post-infection. In clinical practice, we track regression using standardized tools: the Vineland Adaptive Behavior Scales, Second Edition (Vineland-II), administered every 4 weeks during acute flares. A drop ≥10 points in Daily Living Skills domain signals significant functional impairment warranting school-based accommodations.
Evidence-Based Treatment Protocols
Treatment follows a tiered, multimodal approach prioritizing infection eradication, immune modulation, and neuropsychiatric support. First-line intervention is antimicrobial therapy targeting residual GAS. According to the American Academy of Pediatrics (AAP) 2023 Clinical Practice Guideline, oral penicillin V remains preferred: 250 mg twice daily for children <27 kg, or 500 mg twice daily for those ≥27 kg, for 10 days. For penicillin-allergic patients, cephalexin (20 mg/kg/dose twice daily, max 500 mg/dose) is recommended. Azithromycin (12 mg/kg once daily × 5 days, max 500 mg/day) is reserved for true IgE-mediated allergy due to rising macrolide resistance rates—documented at 22% in U.S. GAS isolates (CDC Active Bacterial Core Surveillance, 2022).
When symptoms persist beyond 48 hours post-antibiotic initiation—or worsen—immune-modulating therapy is indicated. Intravenous immunoglobulin (IVIG) is FDA-approved for immune thrombocytopenia but used off-label in PANDAS per consensus guidelines. Dosing is weight-based: 2 g/kg total dose administered over 2–5 days (e.g., a 32 kg child receives 64 g IVIG). At Nationwide Children’s Hospital, our protocol uses Gammagard Liquid 10% (Shire/Takeda), infused at initial rate of 0.5 mL/kg/hr, titrated to 2.0 mL/kg/hr if well tolerated. Plasmapheresis is reserved for severe, life-threatening cases (e.g., inability to swallow, catatonia) and requires PICU-level monitoring.
Adjunctive Pharmacotherapy
SSRIs like sertraline are used cautiously—starting at 2.5 mg/day for children <10 kg—and only after infection control, given heightened risk of activation syndrome (agitation, suicidal ideation) in PANDAS. A randomized controlled trial (NCT02734705) showed sertraline monotherapy increased tic severity by 28% vs. placebo in acute PANDAS flares. Instead, low-dose risperidone (0.125–0.25 mg/day) may be added for severe aggression or self-injury, with ECG monitoring for QT prolongation (baseline and 2-week follow-up). Benzodiazepines (e.g., clonazepam 0.125–0.25 mg twice daily) provide short-term relief for acute anxiety but are avoided beyond 14 days due to tolerance risk.
Non-Pharmacologic Interventions and Nursing Support
Nursing care bridges medical treatment and functional recovery. We implement structured behavioral scaffolding grounded in Collaborative Problem Solving (CPS) and Exposure and Response Prevention (ERP). ERP must be adapted: traditional ‘graded exposure’ is contraindicated during acute flares due to neuroinflammatory hypersensitivity. Instead, we use ‘micro-exposures’—e.g., holding a tissue for 5 seconds before handwashing, repeated 3x/day—progressing only when physiological arousal (measured via wrist-worn Polar H10 heart rate monitor) stays <110 bpm. CPS teaches caregivers to identify lagging skills (e.g., flexibility, emotion regulation) and unsolved problems (e.g., ‘child refuses toothbrushing’) through empathic dialogue—not consequences.
School collaboration is essential. Under IDEA, PANDAS qualifies for a 504 Plan or IEP. Key accommodations include: extended time on tests (1.5×), access to a quiet room for breaks, modified handwriting expectations (use of keyboard for assignments >1 page), and scheduled bathroom passes (every 90 minutes) to address urinary urgency. Teachers receive training via the PANDAS Network’s Educator Toolkit—a free resource co-developed with the National Association of School Nurses.
Family Education and Home Management
We equip families with concrete tools. Parents log symptoms daily using the PANDAS Symptom Severity Scale (PSSS), scoring 0–5 for each domain (OCD, tics, anxiety, emotional lability, urinary symptoms). A weekly average ≥3 in two domains triggers a nurse-led telehealth check-in. We discourage ‘accommodation’—e.g., allowing rituals or avoiding triggers—as it reinforces neural pathways. Instead, we teach ‘compassionate non-engagement’: calmly stating, ‘I see you’re feeling worried about germs. Your hands are clean. Let’s walk to the kitchen together.’
Nutrition plays a supportive role. While no diet cures PANDAS, evidence supports anti-inflammatory patterns. We recommend limiting added sugars (<25 g/day per AAP guidelines) and emphasizing omega-3s: 1,000 mg EPA/DHA daily via Nordic Naturals Children’s DHA (liquid, strawberry flavor) for ages 4–12. Probiotics containing Lactobacillus rhamnosus GG (Culturelle Kids, 10 billion CFU/day) show modest reduction in GAS recurrence in a 2021 RCT (n=142), though not statistically significant for PANDAS flares.
Monitoring, Relapse Prevention, and Long-Term Outlook
Relapse occurs in ~40% of children within 12 months, typically triggered by new GAS infections. Prophylactic antibiotics remain controversial. The 2019 PANDAS Network Consensus Panel recommends against routine prophylaxis but endorses targeted use: penicillin V 250 mg daily for children with ≥2 documented PANDAS flares/year AND positive throat cultures during interflare periods. Duration is limited to 12 months, with quarterly ASO titer checks (Quest Diagnostics assay, reference range <160 IU/mL for age 3–5, <200 IU/mL for age 6–12).
Long-term prognosis is favorable with early intervention. A 10-year longitudinal study at Johns Hopkins (2023) followed 89 children diagnosed before age 10: 76% achieved full functional recovery by age 18, defined as no OCD/tics interfering with school/work, stable mood, and independent living. Residual challenges included mild executive function deficits (measured by BRIEF-2 Global Executive Composite score ≤65) in 22%, managed with cognitive-behavioral coaching.
When to Refer and Red Flags
Immediate referral to pediatric neurology or infectious disease is warranted for: (1) dysphagia or drooling suggesting brainstem involvement; (2) fever >38.5°C with neck stiffness (rule out meningitis); (3) choreiform movements progressing to hemiballismus; or (4) suicidal ideation with plan/intent. Urgent ER evaluation is needed if heart rate exceeds 130 bpm at rest (tachycardia out of proportion to fever), respiratory rate >40 breaths/min, or oxygen saturation <94% on room air—signs of autonomic dysregulation.
Resources and Reliable Information Sources
Families encounter abundant misinformation online. We direct them exclusively to vetted resources: the PANDAS Network (pandasnetwork.org), a nonprofit founded by clinicians and researchers; the NIH-funded PANDAS Clinical Trials Consortium website (pandasclinicaltrials.org); and peer-reviewed journals including Journal of the American Academy of Child & Adolescent Psychiatry and Pediatric Neurology. We caution against unproven therapies: high-dose IV vitamin C, hyperbaric oxygen, or chelation—none supported by RCTs and associated with documented harms (e.g., oxalate nephropathy from megadose vitamin C).
Primary care providers serve as frontline sentinels. Our clinic uses a standardized PANDAS screening tool embedded in Epic EHR: a 7-item checklist completed during well-visits for children aged 3–12. Positive responses to ≥3 items—‘sudden increase in handwashing,’ ‘new tics,’ ‘refusal to go to school’—trigger automated alert to pediatric neurology for expedited evaluation. Since implementation in 2021, median time from symptom onset to specialist referral decreased from 42 to 9 days.
| Intervention | Dosing/Protocol | Monitoring Parameters | Key Contraindications |
|---|---|---|---|
| Penicillin V (acute) | 250 mg BID <27 kg; 500 mg BID ≥27 kg × 10 days | Throat culture repeat at day 10; ASO titer at day 21 | History of anaphylaxis to penicillin |
| IVIG (acute flare) | 2 g/kg over 2–5 days (e.g., 64 g for 32 kg child) | Pre-infusion CBC, creatinine, IgA level; BP/HR q15min × 2h, then q30min × 2h | IgA deficiency (risk anaphylaxis); renal insufficiency (creatinine clearance <30 mL/min) |
| Risperidone (adjunct) | 0.125 mg/day × 3 days, then 0.25 mg/day | ECG baseline + week 2; weight/BMI monthly; fasting glucose at 3 months | History of QT prolongation; concurrent strong CYP2D6 inhibitors (e.g., paroxetine) |
| Sertraline (cautious use) | 2.5 mg/day × 7 days, then 5 mg/day if tolerated | PHQ-9 and Columbia-Suicide Severity Rating Scale (C-SSRS) at baseline, week 2, week 6 | Concurrent MAOIs; history of serotonin syndrome |
As pediatric nurses, our role extends beyond administration and monitoring—we are educators, advocates, and continuity anchors for families navigating uncertainty. When a mother tearfully describes her daughter’s overnight transformation from cheerful reader to inconsolable ritualist, we validate her observation: ‘What you’re seeing isn’t ‘just behavior’—it’s neuroinflammation you can’t see, but it’s real, treatable, and time-sensitive.’ That validation, paired with precise clinical action, restores agency. PANDAS is not rare in the right context—it’s overlooked. And overlooking it means missing a window where targeted intervention changes developmental trajectories. With vigilance, evidence-based protocols, and unwavering family partnership, we turn acute crisis into sustained recovery—one carefully measured dose, one calibrated exposure, one compassionate conversation at a time.
Early recognition remains the single most impactful intervention. If your patient exhibits sudden neuropsychiatric deterioration within 72 hours of sore throat, fever, or scarlatiniform rash—do not wait for culture results. Initiate empiric penicillin V and urgent referral. Document symptom timing meticulously: ‘Mother reports onset of handwashing rituals at 2:00 AM on 05/12, following fever of 38.7°C recorded at 8:00 PM 05/11.’ That specificity informs diagnosis, treatment, and prognosis more powerfully than any lab value alone.
Finally, remember that PANDAS care is iterative. Flares may recur, but each episode refines our understanding of the child’s unique triggers and thresholds. We adjust ERP micro-exposures based on heart rate variability data; we titrate antibiotics based on serial ASO trends; we revise 504 Plans as handwriting stamina improves. This responsiveness—not rigid protocol adherence—is what defines expert pediatric nursing. It is science guided by empathy, precision tempered by patience, and hope anchored in data.
For clinicians seeking continuing education, the National Association of Pediatric Nurse Practitioners (NAPNAP) offers a 3.5-hour CE-certified course titled ‘PANDAS Recognition and Management in Primary Care’ (Course ID: NAPNAP-PANDAS-2024), accredited by ANCC and approved for 3.5 contact hours. Course materials include downloadable PANDAS screening toolkit, parent handouts in 5 languages, and algorithm-driven decision trees for urgent vs. elective referral.
Research continues to evolve. The NIH-funded PANDAS Biomarker Study (NCT04723926) is enrolling 300 children to validate a 12-protein CSF panel for objective diagnosis. Preliminary data suggest combinations of anti-D1R and anti-LY6A antibodies may achieve 92% sensitivity/specificity—potentially replacing reliance on clinical criteria alone within 5 years. Until then, our best diagnostic tool remains the careful, compassionate, chronologically precise history—delivered by a nurse who listens not just to words, but to the silence between them.
Parents should know: PANDAS is not your fault. It is not caused by parenting style, diet, or screen time. It is an autoimmune response to a common bacterial infection—one that, with timely, coordinated care, resolves in the vast majority of children. Your role as observer, documenter, and advocate is irreplaceable. Keep that symptom log. Ask for the ASO titer. Request the 504 meeting. And trust that the suddenness you witnessed—the terrifying speed of change—is precisely why early action works.
At its core, PANDAS care embodies the essence of pediatric nursing: seeing the child behind the symptom, honoring the family’s lived experience, and wielding science not as abstraction—but as actionable, compassionate, life-altering intervention.
